Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments

키워드

참고문헌 (29)

1. Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease : Practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 67, pp.328~357 (2018)
2. Jeong-Ju Yoo, "Recent research trends and updates on nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 25(1), pp.1~11 (2019), 대한간학회
3. 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
4. Lee CM, "A reappraisal of the diagnostic performance of B-mode ultrasonography for mild liver steatosis", Am J Gastroenterol (2022)[DOI]
5. Hamaguchi M, "The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation", Am J Gastroenterol, 102, pp.2708~2715 (2007)
6. 이준혁, "The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults", Clinical and Molecular Hepatology, 28(4), pp.814~826 (2022), 대한간학회
7. Michael H. Le, "Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach", Clinical and Molecular Hepatology, 28(4), pp.841~850 (2022), 대한간학회
8. Nanji AA, "Serum alanine aminotransferase to aspartate aminotransferase ratio and degree of fatty liver in morbidly obese patients", Enzyme, 36, pp.266~269 (1986)
9. Kunde SS, "Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women", Hepatology, 42, pp.650~656 (2005)
10. Browning JD, "Prevalence of hepatic steatosis in an urban population in the United States : impact of ethnicity", Hepatology, 40, pp.1387~1395 (2004)
11. Giboney PT, "Mildly elevated liver transaminase levels in the asymptomatic patient", Am Fam Physician, 71, pp.1105~1110 (2005)
12. Neuschwander-Tetri BA, "Nonalcoholic steatohepatitis : summary of an AASLD Single Topic Conference", Hepatology, 37, pp.1202~1219 (2003)
13. Sorrentino P, "Silent non-alcoholic fatty liver disease-a clinical-histological study", J Hepatol, 41, pp.751~757 (2004)
14. Tahan V, "Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk", Hepatogastroenterology, 55, pp.1433~1438 (2008)
15. Poynard T, "The diagnostic value of biomarkers(SteatoTest)for the prediction of liver steatosis", Comp Hepatol, 4, pp.10~ (2005)
16. Poynard T, "Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data", PLoS One, 7, pp.e30325~ (2012)
17. Bedogni G, "The Fatty Liver Index : a simple and accurate predictor of hepatic steatosis in the general population", BMC Gastroenterol, 6, pp.33~ (2006)
18. Calori G, "Fatty liver index and mortality : the Cremona study in the 15th year of follow-up", Hepatology, 54, pp.145~152 (2011)
19. Lee JH, "Hepatic steatosis index : a simple screening tool reflecting nonalcoholic fatty liver disease", Dig Liver Dis, 42, pp.503~508 (2010)
20. Kotronen A, "Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors", Gastroenterology, 137, pp.865~872 (2009)
21. Yip TC, "Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease(NAFLD)in the general population", Aliment Pharmacol Ther, 46, pp.447~456 (2017)
22. Jeong S, "Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance", Ann Transl Med, 8, pp.1414~ (2020)
23. Zhou YJ, "NAFL screening score : A basic score identifying ultrasounddiagnosed non-alcoholic fatty liver", Clin Chim Acta, 475, pp.44~50 (2017)
24. Zhou YJ, "The NAFL Risk Score : A simple scoring model to predict 4-y risk for non-alcoholic fatty liver", Clin Chim Acta, 468, pp.17~24 (2017)
25. Bedogni G, "A simple index of lipid overaccumulation is a good marker of liver steatosis", BMC Gastroenterol, 10, pp.98~ (2010)
26. Cuthbertson DJ, "External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals", Eur J Endocrinol, 171, pp.561~569 (2014)
27. Otgonsuren M, "Single non-invasive model to diagnose non-alcoholic fatty liver disease(NAFLD)and non-alcoholic steatohepatitis(NASH)", J Gastroenterol Hepatol, 29, pp.2006~2013 (2014)
28. Jung TY, "Comparative assessment and external validation of hepatic steatosis formulae in a community-based setting", J Clin Med, 9, pp.2851~ (2020)
29. Hwi Young Kim, "Recent advances in nonalcoholic fatty liver disease metabolomics", Clinical and Molecular Hepatology, 27(4), pp.553~559 (2021), 대한간학회[DOI]

관련 논문AI추천